Desvenlafaxine

Prescription ·Strong evidence ·Reviewed May 2026

Prescription serotonin-norepinephrine reuptake inhibitor (SNRI) approved for major depressive disorder. The primary active metabolite of venlafaxine, administered as its succinate salt. Offers more predictable pharmacokinetics than venlafaxine since it does not require CYP2D6 metabolism for activation, reducing variability among patients with different CYP2D6 genotypes. Dosage must be determined by your prescribing physician.

What it's good for
  • Depression symptom relief1,4
  • Predictable pharmacokinetics
  • Minimal CYP2D6-dependent metabolism
  • Anxiety symptom improvement4
What to watch for
  • Nausea
  • Dizziness
  • Insomnia
  • Concurrent MAOI use (within 14 days)
  • Known hypersensitivity to desvenlafaxine or venlafaxine1,2

The bottom line

Evidence rating strong. Most-documented uses: depression symptom relief, predictable pharmacokinetics, minimal cyp2d6-dependent metabolism. 10 sources indexed (2015–2023), with 4 interaction records on file.

The science

How it works, mechanistically.

Core mechanism

Inhibits the reuptake of both serotonin (5-HT) and norepinephrine (NE) by blocking SERT and NET. As the active metabolite of venlafaxine, it provides direct dual reuptake inhibition without requiring hepatic activation.

Class
SNRI
Dosing

Dosing & protocol.

Common range
50 mg daily (as prescribed by your physician)
Recommended form
Extended-release tablet

Can be taken with or without food. Swallow whole; do not crush, chew, or dissolve. Taper gradually when discontinuing.

Depletions

What it depletes.

Nutrients this medication can lower over time, and what to replace.

Sodium

Moderate

Antidepressant-associated SIADH can increase renal free-water retention and dilute serum sodium, producing hyponatremia.

Monitor Serum sodiumOnset Often within the first 2 to 4 weeks; can occur later
Safety

Full safety detail.

Side effects

  • Nausea
  • Dizziness
  • Insomnia
  • Hyperhidrosis
  • Constipation
  • Decreased appetite
  • Sexual dysfunction
  • Elevated blood pressure

Contraindications

  • Concurrent MAOI use (within 14 days)
  • Known hypersensitivity to desvenlafaxine or venlafaxine1,2
  • Concurrent use with IV methylene blue or linezolid
  • Uncontrolled narrow-angle glaucoma
Interactions

Interaction records.

DangerousContraindicated

5-HTP

Desvenlafaxine blocks serotonin reuptake, while 5-HTP is converted directly into serotonin. Taking them together can push serotonin signaling into a toxic range and trigger serotonin syndrome, with agitation, tremor, sweating, diarrhea, clonus, fever, and confusion. Risk is higher with dose increases or any other serotonergic drug or substance.

Recommendation: Do not take 5-HTP while using desvenlafaxine. Stop 5-HTP and discuss a washout plan before starting desvenlafaxine. Seek urgent care for fever, muscle rigidity, clonus, severe agitation, or confusion.

DangerousContraindicated

L-Tryptophan

Desvenlafaxine is an SNRI with meaningful serotonin reuptake inhibition, and L-tryptophan is converted into serotonin. Supplemental L-tryptophan can add serotonergic drive to desvenlafaxine and raise the risk of serotonin syndrome. The concern is concentrated supplementation, not normal protein intake.

Recommendation: Do not use L-tryptophan supplements while taking desvenlafaxine. Choose a non-serotonergic sleep or mood support option if needed. If you accidentally combine them, stop the supplement and monitor for agitation, tremor, sweating, diarrhea, fever, or clonus.

DangerousContraindicated

St. John's Wort

St. John's Wort has antidepressant-like serotonergic activity and is a major herb-drug interaction trigger. Combining it with desvenlafaxine can add serotonin reuptake effects and increase the risk of serotonin syndrome. St. John's Wort products vary widely in hyperforin content, making the interaction hard to predict.

Recommendation: Do not combine St. John's Wort with desvenlafaxine. Allow at least a 2-week washout after stopping St. John's Wort before starting or restarting desvenlafaxine unless your prescriber gives a different plan. Avoid other serotonergic substances during the transition.

DangerousContraindicated

MDMA

Desvenlafaxine blocks serotonin and norepinephrine reuptake, and MDMA forces serotonin and norepinephrine release through the same transporter systems. Combining them can blunt desired MDMA effects while increasing risk of serotonin syndrome, hyperthermia, blood pressure spikes, arrhythmia, and seizures. Risk is greater with dehydration, overheating, redosing, or other serotonergic substances.

Recommendation: Do not use MDMA while taking desvenlafaxine. Avoid redosing if MDMA effects feel reduced; blunting does not remove toxicity risk. Seek emergency care for high fever, clonus, confusion, severe agitation, chest pain, fainting, or severe headache.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

1

Randomized controlled trials

6
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Desvenlafaxine in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.